ConductScience.org, home

Paper37541219

FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways.

Huang M and 15 others. Mol Cell, 2023. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways. Papers, record 37541219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37541219

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways.
PubMed
Journal
Mol Cell
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2024-08-04
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang MMin
2Yao FFuwen
3Nie LLitong
4Wang CChao
5Su DDan
6Zhang HHuimin
7Li SSiting
8Tang MMengfan
9Feng XXu
10Yu BBin
11Chen ZZhen
12Wang SShimin
13Yin LLing
14Mou LLisha
15Hart TTraver
16Chen JJunjie

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clustered Regularly Interspaced Short Palindromic RepeatsMajor topic
DNA DamageMajor topic
Humans
Flow Cytometry
Signal Transduction
Ataxia Telangiectasia Mutated Proteins
Genome
Protein-Arginine N-Methyltransferases
Repressor Proteins

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R35 GM130119NIGMS NIH HHSUnited StatesR35GM130119PubMed and NIHNIH RePORTER
R01 CA275712NCI NIH HHSUnited StatesR01CA275712PubMed and NIHNIH RePORTER
R01 CA216437NCI NIH HHSUnited StatesR01CA216437PubMed and NIHNIH RePORTER
R01 CA216911NCI NIH HHSUnited StatesR01CA216911PubMed and NIHNIH RePORTER
P01 CA193124NCI NIH HHSUnited StatesP01CA193124PubMed and NIHNIH RePORTER
P30 CA016672NCI NIH HHSUnited StatesP30CA016672PubMed and NIHNIH RePORTER
R01 CA210929NCI NIH HHSUnited StatesR01CA210929PubMed and NIHNIH RePORTER
R01 CA278758NCI NIH HHSUnited StatesR01CA278758PubMed and NIHNIH RePORTER
R35 CA274234NCI NIH HHSUnited StatesR35CA274234PubMed and NIHNIH RePORTER

Download CSV of grants

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134330913PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.Nat Commun2021https://conductscience.org/library/papers/34330913PubMed
231257072Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.Cancer Cell2019https://conductscience.org/library/papers/31257072PubMed
331230909PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?Trends Mol Med2019https://conductscience.org/library/papers/31230909PubMed
423627586Human RECQL5: guarding the crossroads of DNA replication and transcription and providing backup capability.Crit Rev Biochem Mol Biol2013https://conductscience.org/library/papers/23627586PubMed
524845676DNA replication and oncogene-induced replicative stress.Curr Biol2014https://conductscience.org/library/papers/24845676PubMed
631884170PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes.iScience2020https://conductscience.org/library/papers/31884170PubMed
719011233Supportive evidence for reduced expression of GNB1L in schizophrenia.Schizophr Bull2010https://conductscience.org/library/papers/19011233PubMed
825260700HTSeq--a Python framework to work with high-throughput sequencing data.Bioinformatics2015https://conductscience.org/library/papers/25260700PubMed
99016654Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1.Nucleic Acids Res1996https://conductscience.org/library/papers/9016654PubMed
1032948771Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules.Nat Commun2020https://conductscience.org/library/papers/32948771PubMed
118986806A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8986806PubMed
1211080144Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi-native conformations.EMBO J2000https://conductscience.org/library/papers/11080144PubMed
1332459988Biomarker-Guided Development of DNA Repair Inhibitors.Mol Cell2020https://conductscience.org/library/papers/32459988PubMed
1427912094Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes.Mol Cell2016https://conductscience.org/library/papers/27912094PubMed
1520810650A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability.Genes Dev2010https://conductscience.org/library/papers/20810650PubMed
168769649KAP-1, a novel corepressor for the highly conserved KRAB repression domain.Genes Dev1996https://conductscience.org/library/papers/8769649PubMed
1717525332ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.Science2007https://conductscience.org/library/papers/17525332PubMed
1819690144Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors.Cancer Res2009https://conductscience.org/library/papers/19690144PubMed
1928622525ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.Mol Cell2017https://conductscience.org/library/papers/28622525PubMed
2034983733Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition.Drug Resist Updat2021https://conductscience.org/library/papers/34983733PubMed

See all 89 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42824134Glutamine metabolism and its roles in tumor radiotherapy by regulating DNA damage repair.Front Cell Dev Biol2026https://conductscience.org/library/papers/42824134PubMed
42696584Glucose-TOR-PDCB signaling restricts cell-to-cell communication through callose deposition.Sci Adv2026https://conductscience.org/library/papers/42696584PubMed
42518659Targeting ROAM1 with UDP-GlcNAc nanosheets selective activates lysosomal AMPK to resolve metabolic dysfunction-associated steatotic liver disease.Bioact Mater2026https://conductscience.org/library/papers/42518659PubMed
42484294CRISPR Screening Identifies SMARCAL1 and MRN as Modulators of WRN Dependency in MSI-H Colorectal Cancer.Cancer Res2026https://conductscience.org/library/papers/42484294PubMed
42448898PRMT5 inhibition disrupts detained intron splicing and impairs ATR signaling with increased DNA damage.Commun Biol2026https://conductscience.org/library/papers/42448898PubMed
42146330Parallel Activation and Interference CRISPR (PAIR) with Sequencing Uncovers DNA Repair Networks Guiding Precision Cell Engineering.bioRxiv2026https://conductscience.org/library/papers/42146330PubMed
42041999Methodological Landscape of DNA Damage Response Detection: From Conventional Assays to Future Innovations.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42041999PubMed
41890907PRMT5 inhibition triggers functional ATM deficiency and sensitizes pancreatic cancer to CHK1 blockade.Front Cell Dev Biol2026https://conductscience.org/library/papers/41890907PubMed
41803859Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by promoting aberrant R-loop accumulation.Mol Cancer2026https://conductscience.org/library/papers/41803859PubMed
41601654FACS-based genome-wide CRISPR screening platform identifies modulators of CD47.Front Immunol2025https://conductscience.org/library/papers/41601654PubMed
41580420Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regeneration.Nat Commun2026https://conductscience.org/library/papers/41580420PubMed
41000943Systematic identification and characterization of regulators of aryl hydrocarbon receptor signaling.bioRxiv2025https://conductscience.org/library/papers/41000943PubMed
40875132Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens.Cell Oncol (Dordr)2025https://conductscience.org/library/papers/40875132PubMed
40848933Targeting DNA Topoisomerase I for the Treatment of Cancer: Past, Present and Future.J Mol Biol2026https://conductscience.org/library/papers/40848933PubMed
40679866Identification of Epigenetic Regulators of Vascular Calcification with a CRISPR-Based Screen.J Am Soc Nephrol2025https://conductscience.org/library/papers/40679866PubMed
40650785CRISPR screening approaches in breast cancer research.Cancer Metastasis Rev2025https://conductscience.org/library/papers/40650785PubMed
40578838Optimized derivation and culture system of human naïve pluripotent stem cells with enhanced DNA methylation status and genomic stability.Protein Cell2025https://conductscience.org/library/papers/40578838PubMed
40185091Variant-to-function approaches for adipose tissue: Insights into cardiometabolic disorders.Cell Genom2025https://conductscience.org/library/papers/40185091PubMed
40157940Genome-scale CRISPRi screen identifies pcnB repression conferring improved physiology for overproduction of free fatty acids in Escherichia coli.Nat Commun2025https://conductscience.org/library/papers/40157940PubMed
39778868Cell cycle progression of under-replicated cells.Nucleic Acids Res2025https://conductscience.org/library/papers/39778868PubMed

See all 25 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GNB1L54584Swiss-Prot's referenceshttps://conductscience.org/library/genes/54584NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
PRMT13276PubTator's text mininghttps://conductscience.org/library/genes/3276NCBI Gene
PRMT510419PubTator's text mininghttps://conductscience.org/library/genes/10419NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37541219

GET https://conductscience.org/api/papers/v1/37541219/references?page=2